ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

330
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
07 Jan 2021 04:39

Can You Profit from the KR Retail Investor? (Btw You Already Probably Have Met Him)

I wanted to share my thoughts as I follow the retail moves and share not only who the powerful or mover/shaker Korean retail investor as they now...

Logo
399 Views
Share
12 Dec 2020 03:23

Asia Short Interest: BIG Covering in HK & Korea

There was a big drop in short interest in Hong Kong and Korea while shorts rose in Japan mainly led by ANA on the back of the offering. Shorts in...

Logo
353 Views
Share
07 Nov 2020 10:09

Asia Short Interest Weekly: Rising Shorts in HK, Japan and Taiwan

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest that could be...

Logo
331 Views
Share
26 Oct 2020 07:39

LJY's New Samsung May Begin with Sale of Financial Arm (Life)

LJY's new Samsung may begin by selling the financial arm. The family needs to liquidate the Life shareholding for inheritance tax, but also...

Logo
270 Views
Share
09 Sep 2020 12:18

The Stocks to Own in Asia – Vol. 30

We highlight 14 stocks in Asia that look interesting to us based upon our FVMR Methodology. Our research team constantly reviews the Asia markets...

Share
x